These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 3026004

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Activity of beta-lactamase inhibitors in combination with new beta-lactam antibiotics against resistant gram-negative organisms.
    Bolivar R, Weaver SS, Bodey GP.
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3):255-60. PubMed ID: 6086213
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Activity of 13 beta-lactam agents combined with BRL 42715 against beta-lactamase producing gram-negative bacteria compared to combinations with clavulanic acid, tazobactam and sulbactam.
    Piddock LJ, Jin YF, Turner HL.
    J Antimicrob Chemother; 1993 Jan; 31(1):89-103. PubMed ID: 8383105
    [Abstract] [Full Text] [Related]

  • 25. Induction of chromosomal beta-lactamases by different concentrations of clavulanic acid in combination with ticarcillin.
    Stobberingh EE.
    J Antimicrob Chemother; 1988 Jan; 21(1):9-16. PubMed ID: 3128523
    [Abstract] [Full Text] [Related]

  • 26. [In vitro comparison of the beta lactamase-inhibitory action of clavulanic acid and sulbactam in ampicillin-resistant enterobacteria].
    Grimm H.
    Arzneimittelforschung; 1987 Oct; 37(10):1116-9. PubMed ID: 3501722
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Differences between clavulanic acid and sulbactam in induction and inhibition of cephalosporinases in enterobacteria.
    Kazmierczak A, Cordin X, Duez JM, Siebor E, Pechinot A, Sirot J.
    J Int Med Res; 1990 Oct; 18 Suppl 4():67D-77D. PubMed ID: 2282971
    [Abstract] [Full Text] [Related]

  • 30. Contribution of chromosomal beta-lactamases to beta-lactam resistance in enterobacteria.
    Lindberg F, Normark S.
    Rev Infect Dis; 1986 Oct; 8 Suppl 3():S292-304. PubMed ID: 3529322
    [Abstract] [Full Text] [Related]

  • 31. Inhibition of beta-lactamases by tazobactam and in-vitro antibacterial activity of tazobactam combined with piperacillin.
    Higashitani F, Hyodo A, Ishida N, Inoue M, Mitsuhashi S.
    J Antimicrob Chemother; 1990 Apr; 25(4):567-74. PubMed ID: 2161820
    [Abstract] [Full Text] [Related]

  • 32. Comparative activities of clavulanic acid, sulbactam, and tazobactam against clinically important beta-lactamases.
    Payne DJ, Cramp R, Winstanley DJ, Knowles DJ.
    Antimicrob Agents Chemother; 1994 Apr; 38(4):767-72. PubMed ID: 8031044
    [Abstract] [Full Text] [Related]

  • 33. [Sulbactam and clavulanic acid: studies of enzyme kinetics and synergism with ampicillin and mezlocillin].
    Cullmann W, Binder S, Stieglitz M.
    Immun Infekt; 1987 May; 15(3):103-9. PubMed ID: 3038733
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Use of microdilution panels with and without beta-lactamase inhibitors as a phenotypic test for beta-lactamase production among Escherichia coli, Klebsiella spp., Enterobacter spp., Citrobacter freundii, and Serratia marcescens.
    Thomson KS, Sanders CC, Moland ES.
    Antimicrob Agents Chemother; 1999 Jun; 43(6):1393-400. PubMed ID: 10348759
    [Abstract] [Full Text] [Related]

  • 36. Beta-lactamase production in members of the family Enterobacteriaceae and resistance to beta-lactam-enzyme inhibitor combinations.
    Thomson KS, Weber DA, Sanders CC, Sanders WE.
    Antimicrob Agents Chemother; 1990 Apr; 34(4):622-7. PubMed ID: 2344169
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Characterization of a new TEM-type beta-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coli.
    Blazquez J, Baquero MR, Canton R, Alos I, Baquero F.
    Antimicrob Agents Chemother; 1993 Oct; 37(10):2059-63. PubMed ID: 8257123
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.